Taurolidine in Treating Patients With Recurrent or Progressive Glioma

Clinical trial NCT00022360 · COMPLETED

Trial details

NCT number: NCT00022360
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2001-05-01
Primary completion: 2001-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.